跳至主要内容
临床试验/CTRI/2022/09/045640
CTRI/2022/09/045640进行中(未招募)未知

A clinical investigation evaluating the presence and severity of Diabetic foot neuropathy using VIBRASENSE

Ayati Devices Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Type 1 diabetes over 5 years
  • Type 2 diabetes of any durartion with or withou history of diagnosed diabetic peripheral neuropathy confirmed by medical records
  • Patients who will be able to give written consent

排除标准

  • Active foot ulceration
  • Visual evidence of recently healed foot ulceration
  • Lower limb amputation of any kind or diagnosed peripheral neuropathy of any origin other than diabetes

研究者

发起方
Ayati Devices Private Limited

相似试验